At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,507 enrolled
Drug / intervention
Prospective observational cohort studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
COPD Disease Burden, Patient Characteristics, Maintenance Treatment Patterns and Factors Influencing Treatment Decisions in China Tier 2 and Tier 3 Hospitals
In Brief
An observational study evaluating Prospective observational cohort study for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 1,507 participants across 39 sites.
Detailed Summary
This observational study will be conducted in COPD participants in Tier 2 and 3 hospitals in China to gain an understanding of the complex COPD management and physician's treatment strategy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedApr 2021
Enrollment StartApr 2021
Primary CompletionNov 2022
Study CompletionFeb 2023
TodayJul 2026
First PostedApr 21, 2021
Enrollment StartApr 27, 2021
Primary CompletionNov 3, 2022
Study CompletionFeb 6, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 5.2 years ago
Interventions
Prospective observational cohort studyother
Prospective observational cohort study. No study treatment was administered in this study.